A total of 456 melanoma patients with available survival data were classified into the high IRE1α-signature and low IRE1α-signature groups based on the optimal cutoff value of IRE1α-signature score (high group includes 204 patients and low group includes 252 patients). Here, ERN1 is linked to melanoma.